SFI
ADMA icon

Susquehanna Fundamental Investments’s ADMA Biologics ADMA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,310
Closed -$49.1K – 359
2023
Q2 		$49.1K Hold
13,310
– – ﹤0.01% 622
2023
Q1 		$44.1K Hold
13,310
– – ﹤0.01% 926
2022
Q4 		$51.6K Sell
13,310
-69,003
-84% -$213K ﹤0.01% 1141
2022
Q3 		$200K Buy
+82,313
New +$197K ﹤0.01% 1261

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Susquehanna Fundamental Investments's ADMA Position: Q3 2023 in Review

Susquehanna Fundamental Investments sold out of ADMA Biologics (ADMA) in Q3 2023, closing a stake of 13,310 shares — an estimated $49.1K sold.

Susquehanna Fundamental Investments first reported a position in ADMA in Q3 2022 and held it in 4 quarters. The position peaked at $200K in Q3 2022. 188 funds tracked by Wall St. Rank hold ADMA as of Q3 2023.

  • Susquehanna Fundamental Investments reported no remaining ADMA Biologics position as of Q3 2023 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 13,310 ADMA Biologics shares in Q3 2023, an estimated $49.1K.
  • Susquehanna Fundamental Investments first reported a position in ADMA Biologics in Q3 2022 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's ADMA Biologics position peaked at $200K in Q3 2022.
  • 188 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2023, filed 14 Nov 2023.